Vasculitis of the peripheral nervous system
|
|
- Michael Watkins
- 5 years ago
- Views:
Transcription
1 4 rd Congress of the European Academy of Neurology Lisbon, Portugal, June 16-19, 2018 Teaching Course 5 Acute emergencies in neuromuscular disease - Level 2 Vasculitis of the peripheral nervous system Alexander Vrancken Utrecht, The Netherlands A.F.J.E.vrancken@umcutrecht.nl
2 Conflict of interest: The author has no conflict of interest in relation to this manuscript 1
3 2
4 3
5 4
6 5
7 6
8 7
9 8
10 9
11 10
12 11
13 References: Agadi JB et al. Usefulness of superficial peroneal nerve/peroneus brevis muscle biopsy in the diagnosis of vasculitic neuropathy. J Clin Neurosci. 2012;19(10): Anish L et al, Neuropathy in elderly: lessons learnt from nerve biopsy. Age Ageing. 2015;44(2): Berti A et al. The epidemiology of antineutrophil cytoplasmic autoantibodyassociated vasculitis in Olmsted county, Minnesota: a twenty-year US population-based study. Arthritis Rheumatol. 2017;69(12): Chen DJ, Prayson RA. Evaluation of simultaneous muscle and nerve biopsies for the diagnosis of neuromuscular diseases. Ann Diagn Pathol. 2014;18(5): Chia L et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain. 1996;119 (Pt4): Cho HJ et al. Clinical characteristics and treatment response of peripheral neuropathy in the presence of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): experience at a single tertiary center. J Clin Neurol. 2017;13(1): Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017;13(5): Collins MP et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010;15(3): Duchesne M et al. Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series. Medicine 2015 Jan;94(3):e394. Gwathmey KG et al. Vasculitic neuropathies. Lancet Neurol. 2014;13(1): Hadden RDM et al. Vasculitic peripheral neuropathy: case definition and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine. 2017;35(11): Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5): Kararizou E et al. Polyneuropathies in the elderly: a clinico pathological study of 74 cases. Int J Neurosci May;116(5): Koike H et al. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. J Neurol. 2015;262(3): Kurt S et al. Aymptomatic vasculitic neuropathy. Muscle Nerve 2015;52(1):
14 McCluskey L et al. "Pseudo-conduction block" in vasculitic neuropathy. Muscle Nerve 1999;22(10): Mohammad AJ et al. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology 2009;48(12): Myasoedova E et al. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in versus : a populationbased study. J Rheumatol. 2011;38(6): Nesher G et al. The incidence of primary systemic vasculitis in Jerusalem: a 20-year hospital-based retrospective study. J Rheumatol. 2016;43(6): Ntatsaki E et al. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology 2014;53(1): Said G et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 2002;125(Pt 2): Samson M et al. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors. Autoimmun Rev. 2014;13(9): Suppiah R et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology 2011;50(12): Tracy JA et al. Primary amyloidosis presenting as upper limb multiple mononeuropathies. Muscle Nerve. 2010;41(5): Vital C et al. Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy--a study of 6 new cases. Clin Neuropathol. 2010;29(2): Vital C et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006;11(1):20-9. Vrancken AF, Said G. Vasculitic neuropathy. Handb Clin Neurol. 2013;115: Vrancken AF et al. The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy. Eur J Neurol Jan;18(1): Vrancken AF et al. Immunosuppressive treatment for non-systemic vasculitic neuropathy. Cochrane Database Syst Rev. 2007;(1):CD Watts RA et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant. 2015;30 Suppl 1:i Wolf J et al. Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol. 2013;260(4): Üçeyler N et a. Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J Neurol. 2015;262(9):
Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward
VASCULITIS SYNDROMES Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward ILLUSTRATED CASE 1 A 56 years old lady refered me for prolonged fever, arthritis
More informationANCA associated vasculitis in China
ANCA associated vasculitis in China Min Chen Renal Division, Peking University First Hospital, Beijing 100034, P. R. China 1 General introduction of AAV in China Disease spectrum and ANCA type Clinical
More informationDr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology
Vasculitis Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Disease Spectrum Hypersensitivity vasculitis/microscopic
More informationPlasma exchanges in ANCA-associated vasculitis
Plasma exchanges in ANCA-associated vasculitis Xavier Puéchal, MD, PhD Centre de Référence des Maladies auto-immunes systémiques rares d Ile de France Hôpital Cochin Université Paris Descartes http://www.vascularites.org
More informationW egener s granulomatosis (WG), Churg Strauss syndrome
PAPER Peripheral neuropathy in Wegener s granulomatosis, Churg Strauss syndrome and microscopic polyangiitis Luigi Cattaneo, Elisabetta Chierici, Laura Pavone, Chiara Grasselli, Paolo Manganelli, Carlo
More informationJCN Open Access INTRODUCTION ORIGINAL ARTICLE
JCN Open Access pissn 1738-6586 / eissn 2005-5013 / J Clin Neurol 2017;13(1):77-83 / https://doi.org/10.3988/jcn.2017.13.1.77 ORIGINAL ARTICLE Clinical Characteristics and Treatment Response of Peripheral
More informationRate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis
Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis M. Jung 1, L. Barra 2 1 Division of Rheumatology, Department of Medicine, University
More informationDiagnostic Procedures for Vasculitis
Diagnostic Procedures for Vasculitis Toshiharu Matsumoto, MD Clinical Professor of Department of Diagnostic Pathology Juntendo University Nerima Hospital, Tokyo, Japan Introduction In 1994, the International
More informationClinical characteristics and outcome of vasculitides
GENERAL SECTION ORIGINAL ARTICLE Clinical characteristics and outcome of vasculitides Buddhi Prasad Paudyal, 1 Madhu Gyawalee 2 ISSN: 2091-2749 (Print) 2091-2757 (Online) Correspondence Dr. Buddhi Prasad
More informationCASE REPORT. Abstract. Introduction. Case Reports
CASE REPORT Efficacy of Early Intravenous Immunoglobulin for Eosinophilic Granulomatosis with Polyangiitis with Drastically Progressive Neuropathy: A Synopsis of Two Cases Takeshi Matsumoto 1, Kojiro Otsuka
More informationTell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital
Tell me more about vasculitis Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Talk overview Case study ANCA-associated vasculitis What is ANCA vasculitis? What causes ANCA
More informationDifferential Diagnosis of Neuropathies and Compression. Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre
Differential Diagnosis of Neuropathies and Compression Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre Outline of talk Mononeuropathies median and anterior interosseous nerve ulnar nerve
More informationVasculitides in Surgical Neuropathology Practice
Vasculitides in Surgical Neuropathology Practice USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationEDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link
EDITORIAL, October 2004 Welcome to the Spring 2004 Edition of InfoLink. The feature article in this edition has been written by Dr Rodger Laurent, Head of Department, PaLMS Rheumatology Laboratory. The
More informationRenal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis
Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis E.S. Park, S.S. Ahn, S.M. Jung, J.J. Song, Y.-B. Park, S.-W. Lee Division of Rheumatology, Department of Internal
More informationAN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS
GRANULOMATOSIS WITH POLYANGIITIS (GPA), MICROSCOPIC POLYANGIITIS (MPA), and EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS What is ANCA-associated Vasculitis?
More informationDecember 6, 2010 Asthma and Rheumatic Disorders and Vasculitis
December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis Lanny J. Rosenwasser, M.D. Dee Lyons/Missouri Endowed Chair in Immunology Research Professor of Pediatrics Allergy-Immunology Division Childrens
More informationRecent advances in management of Pulmonary Vasculitis. Dr Nita MB
Recent advances in management of Pulmonary Vasculitis Dr Nita MB 23-01-2015 Overview of the seminar Recent classification of Vasculitis What is new in present classification? Trials on remission induction
More informationDisease flares, damage accrual and survival in ANCA-associated vasculitis in Western Australia
International Journal of Clinical Rheumatology Disease flares, damage accrual and survival in ANCA-associated vasculitis in Western Australia Background: ANCA-associated vasculitis (AAV) is a potentially
More informationVasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis
Edward Dwyer, M.D. Division of Rheumatology VASCULITIS is a primary inflammatory disease process of the vasculature Determinants of the Clinical Manifestations of : Target organ involved Size of vessel
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A ANCA vasculitis. See Antineutrophil cytoplasmic antibody associated (ANCA) vasculitis Angiography 54 Antineutrophil cytoplasmic antibody correlation
More informationSmall Vessel Vasculitis
Small Vessel Vasculitis Paul A Brogan Professor of Vasculitis and Consultant Paediatric Rheumatologist Department of Rheumatology Institute of Child Health and Great Ormond St Hospital, London UK P.brogan@ucl.ac.uk
More informationSHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth
SHO Teaching Vasculitis Renal medicine Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth OUTLINE What is vasculitis Causes Classification Brief look into ANCA Associated Vasculitis (AAV)
More informationAtlas of the Vasculitic Syndromes
CHAPTER e40 Atlas of the Vasculitic Syndromes Carol A. Langford Anthony S. Fauci Diagnosis of the vasculitic syndromes is usually based upon characteristic histologic or arteriographic findings in a patient
More informationThe use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study
Research paper See Editorial Commentary, p 1307 c Supplementary tables 1 3 are published online only at http:// jnnp.bmj.com/content/vol79/ issue12 1 Wellcome Clinical Scientist Fellow King s College and
More informationSMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018
SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018 OUTLINE Renal involvement in vasculitis Curr Rheumatol Rep 2013 Renal involvement in ANCA vasculitis GN***:
More informationEUVAS update June 5 th Marinka Twilt
EUVAS update June 5 th 2012 Marinka Twilt Chapel Hill 2012 Classification Large Vessel Vasculitis (LVV) Medium Vessel Vasculitis (MVV) Small Vessel Vasculitis (SVV) Variable Vessel Vasculitis (VVV) Single
More informationGRANULOMATOSIS WITH POLYANGIITIS
What is granulomatosis with polyangiitis (GPA)? Granulomatosis with polyangiitis (GPA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict
More informationNucala (mepolizumab) Prior Authorization Protocol
Nucala (mepolizumab) Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review of medical
More informationPR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening
PR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening Stephen Holding PhD FRCPath Consultant Clinical Scientist Hull & East Yorkshire Hospitals steve.holding@hey.nhs.uk
More informationVASCULITIS. Case Presentation. Case Presentation
VASCULITIS Case Presentation The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have
More information4/20/18. Kelly G. Gwathmey, MD University of Virginia April 23, 2018
Kelly G. Gwathmey, MD University of Virginia April 23, 2018 Outline Vasculitic Neuropathies Autoimmune Small Fiber Neuropathies Sensory Neuronopathies (Dorsal Root Ganglionopathies) Other Autoimmune Large
More informationVasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi
Vasculitis and Vasculitides OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi Definition Presence of leucocytes in the vessel wall with reactive damage
More informationRituximab treatment for ANCA-associated vasculitis in childhood
Rituximab treatment for ANCA-associated vasculitis in childhood DISCLOSURE I have no relevant financial relationships to disclose Katharine Moore MD Nov 14, 2012 University of Colorado School of Medicine
More informationClinical analysis of nervous system involvement in ANCA-associated systemic vasculitides
Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides W. Zhang, G. Zhou*, Q. Shi, X. Zhang, X.-F. Zeng, F.-C. Zhang Department of Rheumatology, Peking Union Medical College
More informationElevated serum levels of immunoglobulin A correlate with the possibility of readmission in patients with microscopic polyangiitis
Original Article Elevated serum levels of immunoglobulin A correlate with the possibility of readmission in patients with microscopic polyangiitis Huijuan Wang, Chao Zhang, Zhaohui Tong, Xiaoning Bu Department
More informationSmall Vessel Vasculitis
Banff- Rocky Mountain Barry Kassen, MD, FRCPC,FACP Head, Division of Internal Medicine UBC/VGH/SPH Acting Head, Division of Community Internal Medicine November, 2009 Objectives 1. To understand small
More informationClinical Study Necrotizing Lymphocytic Vasculitis Limited to the Peripheral Nerves: Report of Six Cases and Review
International Rheumatology Volume 2009, Article ID 368032, 5 pages doi:10.1155/2009/368032 Clinical Study Lymphocytic Vasculitis Limited to the Peripheral Nerves: Report of Six Cases and Review JoséFélix
More informationTREATMENT OF ANCA-ASSOCIATED VASCULITIS
TREATMENT OF ANCA-ASSOCIATED VASCULITIS Loïc Guillevin Hôpital Cochin, Université Paris Descartes Cours DU, 11 mars 2016 1 Disclosure of interest regarding this presentation Roche has provided, in part,
More informationNIH Public Access Author Manuscript Ann Rheum Dis. Author manuscript; available in PMC 2011 July 19.
NIH Public Access Author Manuscript Published in final edited form as: Ann Rheum Dis. 2009 January ; 68(1): 103 106. doi:10.1136/ard.2008.097758. Comparison of disease activity measures for anti-neutrophil
More informationTitle. CitationClinical Neurology and Neurosurgery, 111(8): Issue Date Doc URL. Type. File Information
Title Clinical characterization and successful treatment o Nakamura, Masakazu; Yabe, Ichiro; Yaguchi, Hiroaki; Author(s) Hideki; Tsuji-Akimoto, Sachiko; Niino, Masaaki; Sasa CitationClinical Neurology
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 08/19/14 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
RITUXAN (rituximab) Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline
More informationAnnual Rheumatology & Therapeutics Review for Organizations & Societies
Annual Rheumatology & Therapeutics Review for Organizations & Societies Update on Granulomatosis with Polyangiitis (Wegener s) Learning Objectives Identify the clinical features of granulomatosis with
More informationEULAR/ERA-EDTA recommendations for the management of ANCAassociated
EULAR/ERA-EDTA recommendations for the management of ANCAassociated vasculitis Dr. Meharunnisha Syed III year DNB Resident (General Medicine) Narayana Health-MSH Fifteen recommendations were developed,
More informationPAEDIATRIC VASCULITIS
PAEDIATRIC VASCULITIS Lawrence Owino Okong o, Mmed (UoN); Mphil. (UCT). Lecturer, Department of Paediatrics and Child Health, University of Nairobi. Paediatrician/ Rheumatologist. OUTLINE Introduction
More informationVasculitis local: systemic
Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated 2- infectious
More informationVasculitis Prof. Dr. med. Katharina Glatz Pathologie
Vasculitis 08-21-2018 Prof. Dr. med. Katharina Glatz Pathologie Agenda Anatomy and histology Vasculitis: Chapel Hill Classification Examples Giant cell arteritis Single organ vasculitis Artery or Vein?
More informationCase Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis
Case Presentation VASCULITIS The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have
More informationChapter 2 Animal Models of ANCA-Associated Vasculitides
Chapter 2 Animal Models of ANCA-Associated Vasculitides Domenico Ribatti and Franco Dammacco Abstract Antibodies against neutrophil proteins myeloperoxidase (MPO) and proteinase- 3 (PR3) are responsible
More informationRelation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis
Houben et al. BMC Nephrology (2017) 18:378 DOI 10.1186/s12882-017-0797-x RESEARCH ARTICLE Open Access Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis Eline
More informationTreatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome
Q J Med 2007; 100:41 51 doi:10.1093/qjmed/hcl125 Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome L. MATHEW 1, K. TALBOT 2, S. LOVE 3, S. PUVANARAJAH 2 and M. DONAGHY
More informationKAWASAKI DISEASE. What is Kawasaki disease? Causes
What is Kawasaki disease? Kawasaki disease is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and
More informationOlder patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study
Manno et al. BMC Nephrology (2015) 16:88 DOI 10.1186/s12882-015-0082-9 RESEARCH ARTICLE Open Access Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective
More informationScleritis LEN V KOH OD
Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2
More informationComplicated Acute Motor Axonal Neuropathy with Delayed Acute Respiratory Distress Syndrome and Rapidly Progressive Glomerulonephritis: a Case Report
26 Complicated Acute Motor Axonal Neuropathy with Delayed Acute Respiratory Distress Syndrome and Rapidly Progressive Glomerulonephritis: a Case Report An-Chih Chen 1,6,7, Chiu-Mei Chen 1,6,7, Horng-Rong
More informationVasculitis local: systemic
Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated inflammation
More informationCENTRAL NERVOUS SYSTEM VASCULITIS
What is central nervous system (CNS) vasculitis? Central nervous system (CNS) vasculitis is among a family of rare disorders characterized by inflammation of the blood vessels, which restricts blood flow
More informationClinical Commissioning Policy: Rituximab For ANCA Vasculitis. December Reference : NHSCB/ A3C/1a
Clinical Commissioning Policy: Rituximab For ANCA Vasculitis December 2012 Reference : NHSCB/ A3C/1a NHS Commissioning Board Clinical Commissioning Policy: Rituximab For The Treatment Of Anti-Neutrophil
More informationPresenting Features in Pakistani Patients Suffering from the Antineutrophil Cytoplasmic Antibody - Classical Subtype (c- ANCA) Associated Vasculitis
Presenting Features in Pakistani Patients Suffering from the Antineutrophil Cytoplasmic Antibody - Classical Subtype (c- ANCA) Associated Vasculitis Tahir Aziz Ahmed,Abdul Halim,Tassawar Hussain,Nadeem
More informationMicroscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report
Fukushima et al. BMC Gastroenterology 2013, 13:42 CASE REPORT Open Access Microscopic polyangiitis complicated with ileal involvement detected by double-balloon endoscopy: a case report Masashi Fukushima
More informationGIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.
What is giant cell arteritis (GCA)? Giant cell arteritis (GCA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage
More informationClassification and classification criteria for vasculitis: achievements, limitations and prospects
REVIEW C URRENT OPINION Classification and classification criteria for : achievements, limitations and prospects Alfred Mahr a,b and Mathilde de Menthon a Purpose of review The classification of s reveals
More informationANCA-associated vasculitis. Vladimir Tesar Department of Nephrology, General University Hospital, Prague, Czech Republic
ANCA-associated vasculitis Vladimir Tesar Department of Nephrology, General University Hospital, Prague, Czech Republic Disclosure of Interests Abbvie, Amgen, Baxter, Bayer, Boehringer-Ingelheim, Calliditas,
More informationCombined Allergic Bronchopulmonary Aspergillosis and Eosinophilic Granulomatosis with Polyangiitis: Three Cases and a Review of the Literature
CASE REPORT Combined Allergic Bronchopulmonary Aspergillosis and Eosinophilic Granulomatosis with Polyangiitis: Three Cases and a Review of the Literature Takashi Ishiguro, Noboru Takayanagi, Yotaro Takaku,
More informationSensory mononeuritis: differentiating pure neural leprosy from non-systemic vasculitic neuropathy
Lepr Rev (2017) 88, 274 279 CASE REPORT Sensory mononeuritis: differentiating pure neural leprosy from non-systemic vasculitic neuropathy PINELOPI TSOUNI*, JOHANNES ALEXANDER LOBRINUS**, ANDREAS J. STECK*
More informationOBSERVATION. Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome
OBSERVATION Initial Cutaneous Manifestations Consistent With Mononeuropathy Multiplex in Churg-Strauss Syndrome Tamihiro Kawakami, MD, PhD; Yoshinao Soma, MD, PhD; Kanade Kawasaki, MD; Ayumi Kawase, MD;
More informationRenal transplantation in ANCA-associated vasculitis
Renal transplantation in ANCA-associated vasculitis Mårten Segelmark Linköping University Post Print N.B.: When citing this work, cite the original article. Original Publication: Mårten Segelmark, Renal
More informationAnti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease
Anti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease Grace M. Lee, Yara A. Park, Marshall Mazepa, Jay S. Raval Introduction Anti-neutrophil
More informationRARE JUVENILE PRIMARY SYSTEMIC VASCULITIS
www.pediatric-rheumathology.printo.it RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS WHAT IS IT? Vasculitis is an inflammation of blood vessels. Vasculitides cover a wide group of diseases. Primary vasculitis
More informationThe role of pathology in the diagnosis of systemic vasculitis
Clinical and Experimental Rheumatology 2007; 25: S52-S56 The role of pathology in the diagnosis of systemic vasculitis J.C. Jennette 1, R.J. Falk 2 1 Brinkhous Distinguished Professor and Chair of Pathology
More informationEmployment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study
Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study L. Benarous 1, B. Terrier 1, H. Laborde-Casterot 2, A. Bérezné 1, B. Dunogué 1, P. Cohen
More informationEfficacy and Safety of Rituximab in the Treatment of Rheumatoid Arthritis and ANCA-associated Vasculitis
New Evidence reports on presentations given at ACR/ARHP 2010 Efficacy and Safety of Rituximab in the Treatment of Rheumatoid Arthritis and ANCA-associated Vasculitis Report on ACR/ARHP 2010 presentations
More informationReview Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar
Review Article Vidarbha Journal of Internal Medicine Volume 23 July 207 Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis Milind Aurangabadkar ABSTRACT Anti-neutrophil
More informationUpdate on nomenclature and classification of vasculitis
Update on nomenclature and classification of vasculitis Mohammadreza Shakibi M.D. Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward Adolph Kussmaul (1822 1902) First Modern
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jones RB, Cohen Tervaert JW, Hauser T, et al. Rituximab versus
More informationPrimary systemic vasculitis: clinical features and mortality
Q J Med 2005; 98:97 111 doi:10.1093/qjmed/hci015 Advance Access publication 17 January 2005 Original papers Primary systemic vasculitis: clinical features and mortality S.E. LANE, R.A. WATTS, L. SHEPSTONE
More informationA number of factors point to the likelihood of a person with RA developing RV:
What is rheumatoid vasculitis (RV)? Rheumatoid vasculitis (RV) is a rare but serious complication of rheumatoid arthritis (RA) an inflammatory disease that causes severe joint pain and damage, and can
More informationLong-term outcome of patients with ANCAassociated vasculitis treated with plasma exchange: a retrospective, single-centre study
Frausová et al. Arthritis Research & Therapy (2016) 18:168 DOI 10.1186/s13075-016-1055-5 RESEARCH ARTICLE Open Access Long-term outcome of patients with ANCAassociated vasculitis treated with plasma exchange:
More informationImmunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
Clinical Kidney Journal, 2017, vol. 10, no. 4, 470 474 doi: 10.1093/ckj/sfx014 Advance Access Publication Date: 12 April 2017 Original Article ORIGINAL ARTICLE Immunoglobulin levels and infection risk
More informationUpdate and Review on Vasculitis. Ramona Raya, MD ACP Internal Medicine Congress August 7, 2015
Update and Review on Vasculitis Ramona Raya, MD ACP Internal Medicine Congress August 7, 2015 Outline Classification and nomenclature updates Small vessel vasculitis Pathophysiology Diagnosis Management/therapeutic
More informationFAQ Identifying and enrolling participants
FAQ Identifying and enrolling participants WHO IS ELIGIBLE - CASES? Patients with a new diagnosis of primary systemic vasculitis Patients suitable as cases are over 18 years with a new presentation or
More informationThe systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D.
60 Treatment of ANCA-associated Systemic Vasculitis H. Michael Belmont, M.D. Abstract The antineutrophil cytoplasmic antibodies (ANCA)-associated small vessel vasculitides include Wegener s granulomatosis,
More informationVASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018
VASCULITIC SYNDROMES Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018 2012 REVISED CHAPEL HILL CONSENSUS CONFERENCE Large vessel Takayasu arteritis Giant cell arteritis Medium Vessel Polyarteritis
More informationGlucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease
Article Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease JulieAnne G. McGregor, Susan L. Hogan, Yichun Hu, Caroline E. Jennette, Ronald J. Falk, and Patrick
More informationThe Incidence, Prevalence and Mortality of Granulomatosis with Polyangiitis in the UK Clinical Practice Research Datalink.
The Incidence, Prevalence and Mortality of Granulomatosis with Polyangiitis in the UK Clinical Practice Research Datalink. AUTHORS: Fiona A Pearce, Division of Epidemiology and Public Health, University
More informationVasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP
Vasculitis Update A selective review of what s new Dr Jonathan Akikusa MBBS FRACP Consultant Paediatric Rheumatologist Royal Children s Hospital, Melbourne Honorary Research Fellow Murdoch Children s Research
More informationA Study of Atherosclerosis in Systemic Vasculitis
Original Article A Study of Atherosclerosis in Systemic Vasculitis Silas Supragya Nelson, Sonjjay Pande, Avadhesh Pratap Singh Kushwah 3 Assistant Professor in the Department of Medicine, NSCB Medical
More informationCitation for published version (APA): Chen, M. (2009). Pathogenetic and clinical aspects of ANCA-associated vasculitis Groningen: s.n.
University of Groningen Pathogenetic and clinical aspects of ANCA-associated vasculitis Chen, Min IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationC irculating endothelial cells (CECs) are a new marker of
164 EXTENDED REPORT Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis A Woywodt, C Goldberg, T Kirsch, K de Groot, U Erdbruegger, H Haller, M
More informationVasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)
Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) J. Charles Jennette Ronald J. Falk The kidneys are affected by a variety of systemic vasculitides
More informationManaging Acute Medical Problems, Birmingham Vasculitis. David Jayne. University of Cambridge
Managing Acute Medical Problems, Birmingham 2016 Vasculitis David Jayne University of Cambridge Disclosures Astra Zeneca, Aurinia, BIOGEN, Boehringer, Chemocentryx, Genzyme/Sanofi, GSK, Lilly, Medimmune,
More informationANCA+ VASCULITIDES CYCAZAREM,
ANCA+ VASCULITIDES CYCAZAREM, q Comparison of 3 to 6 mo. oral CYC + CS then azathioprine or oral CYC for 12 mo.+ 10 mg/d CS. After 12 mo all the patients were treated with azathioprine q 150 patients followed
More informationA prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature
478 Bispebjerg Hospital, 2400 Copenhagen NV, Denmark S F Sørensen Hvidovre Hospital, Hvidovre, Denmark O Slot N Tvede Rigshospitalet, National University Hospital, Copenhagen, Denmark J Petersen Correspondence
More informationWartenberg s migrant sensory neuritis: a prospective follow-up study
J Neurol (2010) 257:1344 1348 DOI 10.1007/s00415-010-5530-7 ORIGINAL COMMUNICATION Wartenberg s migrant sensory neuritis: a prospective follow-up study Abraham C. J. Stork Marjon F. G. van der Meulen W.-Ludo
More informationCurrent Status of Outcome Measures in Vasculitis: Focus on Wegener s Granulomatosis and Microscopic Polyangiitis. Report from OMERACT 7
OMERACT 7 Special Interest Group Current Status of Outcome Measures in Vasculitis: Focus on Wegener s Granulomatosis and Microscopic Polyangiitis. Report from OMERACT 7 PETER A. MERKEL, PHILIP SEO, PETER
More informationClinical Features of Microscopic Polyangiitis: A Cohort Study in a Southern Taiwan Medical Center
Acta Nephrologica 26(4): 198-5, 12 DOI: 1.6221/AN.1128 Original Article Clinical Features of Microscopic Polyangiitis: A Cohort Study in a Southern Taiwan Medical Center Chun-Kai Huang 1, 3, Hua-Chang
More informationReviews in Clinical Medicine
Mashhad University of Medical Sciences (MUMS) Reviews in Clinical Medicine Clinical Research Development Center Ghaem Hospital Churg-Strauss Syndrome in a Seven-year-old Boy: A Case Report Abdolreza Malek
More informationThe European and French networks. Christian Pagnoux, MD, MSc, MPH Mount Sinai Hospital, Toronto, Canada Cochin Hospital, Paris, France
The European and French networks Christian Pagnoux, MD, MSc, MPH Mount Sinai Hospital, Toronto, Canada Cochin Hospital, Paris, France French Vasculitis Study Group December 1980: L. Guillevin no research,
More informationANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TESTING GUIDELINES
ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TESTING GUIDELINES Version: 1.0 Ratified by: Clinical Biochemistry Senior Staff Group Date ratified: Name of originator/author: Director responsible for implementation:
More informationT he primary systemic vasculitides (PSV) are clinically
605 EXTENDED REPORT EULAR recommendations for conducting clinical studies and/ or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Bernhard Hellmich,
More information